Presbyopia-correcting drop and pandemic protocols lead March ophthalmology news
The top ophthalmology stories in March included the FDA acceptance of an investigational new drug application for a presbyopia-correcting drop and a look at ophthalmology protocols during the pandemic.
Read the best-performing ophthalmology articles below:
FDA accepts IND for presbyopia drop
The FDA has accepted an investigational new drug application for Brimochol, according to a press release from Visus Therapeutics. Read more.
COVID-19 practice protocols may remain after pandemic ends
The American Academy of Ophthalmology has helped physicians reduce the risk for SARS-CoV-2 transmission in their practices, and some safety measures may be here to stay. Read more.
Study finds pregnancy a contraindication for refractive surgery
A study investigating the outcomes of LASIK and PRK in women who underwent refractive surgery while unaware of their pregnancy found significantly worse results compared with those who were not pregnant. Read more.
Q&A: Visual hallucinations may have worsened during pandemic
The COVID-19 pandemic may have exacerbated Charles Bonnet syndrome in some patients with low vision who experience visual hallucinations, according to a study. Read more.
Q&A: Air pollution increases risk for AMD
Air pollution is a health hazard, and not only for the lungs. The eyes, and particularly the delicate layers of the retina, may be affected, and chronic exposure may trigger or speed up the mechanisms that lead to age-related degenerative eye diseases. Read more.